MktsMarkets
Johnson & Johnson
NYSE: JNJKey statistics
JNJ News
Stories mentioning JNJ from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 29 | Q4 '25Dec 28 | Q3 '25Sep 28 | Q2 '25Jun 29 | Q1 '25Mar 30 | Q4 '24Dec 29 | Q3 '24Sep 29 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 24,062,000 | 24,564,000 | 23,993,000 | 23,743,000 | 21,893,000 | 22,520,000 | 22,471,000 | 22,447,000 |
| Cost of Goods Sold | 8,106,000 | 7,968,000 | 7,303,000 | 7,628,000 | 7,357,000 | 7,128,000 | 6,963,000 | 6,869,000 |
| Gross Profit | 15,956,000 | 16,596,000 | 16,690,000 | 16,115,000 | 14,536,000 | 15,392,000 | 15,508,000 | 15,578,000 |
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 6,034,000 | 6,753,000 | 5,922,000 | 5,889,000 | 5,112,000 | 6,453,000 | 5,478,000 | 5,681,000 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | ||||||||
| Interest Income | 229,000 | 237,000 | 227,000 | 260,000 | 332,000 | 281,000 | 292,000 | 395,000 |
| Interest Expense | ||||||||
| Other Expense | (294,000) | (483,000) | 478,000 | (107,000) | 7,321,000 | 161,000 | (1,798,000) | (653,000) |
| Pretax Income | 5,990,000 | 4,966,000 | 7,493,000 | 6,491,000 | 13,631,000 | 3,887,000 | 3,338,000 | 5,748,000 |
| Tax Provision | 755,000 | (150,000) | 2,341,000 | 954,000 | 2,632,000 | 456,000 | 644,000 | 1,062,000 |
| Net Income (Loss) | 5,235,000 | 5,116,000 | 5,152,000 | 5,537,000 | 10,999,000 | 3,431,000 | 2,694,000 | 4,686,000 |
| Earnings Per Share (Basic) | 2.17 | 2.13 | 2.14 | 2.30 | 4.57 | 1.43 | 1.12 | 1.95 |
| Earnings Per Share (Diluted) | 2.14 | 2.11 | 2.12 | 2.29 | 4.54 | 1.41 | 1.11 | 1.93 |
| Weighted Average Shares Outstanding (Basic) | 2,408,700 | 2,407,400 | 2,408,300 | 2,406,300 | 2,407,200 | 2,407,300 | 2,407,200 | 2,406,800 |
| Weighted Average Shares Outstanding (Diluted) | 2,445,200 | 2,429,400 | 2,428,600 | 2,419,100 | 2,423,800 | 2,429,400 | 2,427,900 | 2,422,000 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About JNJ
Johnson & Johnson (NYSE: JNJ) is a stock listed on the New York Stock Exchange under the ticker symbol JNJ. It last traded at $255.56 (Oct 16, 2026, 4:00 PM ET), up 0.9% on the day. That gives Johnson & Johnson a market capitalisation of $624.0B and a price-to-earnings ratio of 38.8.
Over the past 52 weeks JNJ has traded between $184.66 and $281.07.
Revenue for the quarter ended Mar 29, 2026 was $24.1B; net income $5.2B. Revenue was up 9.9% from $21.9B in the quarter ended Mar 30, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 29, 2026 | $24.1B | $5.2B | 21.8% |
| Dec 28, 2025 | $24.6B | $5.1B | 20.8% |
| Sep 28, 2025 | $24.0B | $5.2B | 21.5% |
| Jun 29, 2025 | $23.7B | $5.5B | 23.3% |
From Johnson & Johnson’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…